Myeloproliferative neoplasms are a group of rare, slow-growing blood cancers characterized by the overproduction of blood cells in the bone marrow, leading to various blood disorders and complications.
Hyperbaric Oxygen Therapy may support the management of Myeloproliferative neoplasms by enhancing oxygen delivery to compromised tissues, promoting stem cell proliferation and migration, and potentially alleviating disease-related symptoms.